Ngwube A., Unrelated donor hematopoietic stem cell transplantation for sickle cell disease 2017
Publications
Transplantation and cellular therapy Hans Rhea, Retrospective Analysis of Fresh Vs Cryopreserved Allogenic Bone Marrow Transplant within Pediatric Population: A Change in Practice Due to COVID-19 Pandemic 30:2, p. S246 - S246 2024
Transplantation and cellular therapy Rahim Mahvish Qureshi, Impact of CMV Reactivation on Clinical Outcomes Post Allogeneic Stem Cell Transplant in Patients with Sickle Cell Disease 30:2, p. S302 - S302 2024
Transplantation and cellular therapy Horan Fiona, Preservation of Pulmonary Function Following Hematopoietic Cell Transplant for Sickle Cell Disease: A STAR Study 30:2, p. S45 - S46 2024
Pediatrics (Evanston) Booth Natalie, Reversal of Cerebral Arteriopathy Post-Hematopoietic Stem Cell Transplant for Sickle Cell Disease 2024
Bone marrow transplantation (Basingstoke) Gabelli Maria, Abatacept treatment for autoimmune hemolytic anemia occurring post hematopoietic stem cell transplantation 2023
Blood Stenger Elizabeth, Donor Hemoglobin Genotype Does Not Impact Outcomes Following Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Study 142:Supplement 1, p. 4955 - 4955 2023
Blood Ngwube Alexander I., Abatacept-Prophylaxis Based Haploidentical Transplantation May Allow Sustained Engraftment and Offset Gvhd in Non-Malignant Disorders 142:Supplement 1, p. 4901 - 4901 2023
Blood John Tami D., Regimen Intensity and Age Affect Transplant-Related Outcomes after Matched Related Donor Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Registry Study 142:Supplement 1, p. 4904 - 4904 2023
Blood Shah Niketa C., Outcomes after RIC and Abatacept-Based Acute and Chronic Gvhd Prophylaxis in Allogeneic Transplantation for Sickle Cell Disease - Can Calcineurin Inhibitor Use be Curtailed? 142:Supplement 1, p. 2185 - 2185 2023
Current opinion in hematology Shah Niketa C., Mixed donor chimerism following stem cell transplantation for sickle cell disease 2023
Transplantation and cellular therapy Booth Natalie, Efficacy of Azacitidine and Prophylactic Donor Lymphocyte Infusion after HSCT in Pediatric Patients with Acute Myelogenous Leukemia: A Retrospective Pre-Post Study 29:5, p. 330.e1 - 330.e7 2023
Transplantation and cellular therapy Guilcher Gregory MT, 391 - Clinical Outcomes and Long-Term Follow-up of Children with Mixed Myeloid Chimerism Following Hematopoietic Cell Transplantation (HCT) for Sickle Cell Disease (SCD) 29:2, p. S296 - S297 2023
Transplantation and cellular therapy Kasow Kimberly A., 387 - Curing Children with Sickle Hemoglobinopathies of Varying Severity Early in Life with HLA-Matched Sibling Donor (MSD) Hematopoietic Cell Transplantation (HCT) Following a Reduced Intensity Conditioning (RIC) Regimen: A Sickle Transplant, Advocacy, a 29:2, p. S293 - S294 2023
Pediatric Blood and Cancer Shah A., Investigating racial disparities in quality-of-life years after pediatric hematopoietic stem cell transplant 70:9 2023
Therapeutic Advances in Hematology Ngwube A., Role of abatacept in the prevention of graft-versus-host disease: current perspectives 14 2023
Pediatric Hematology and Oncology Ngwube A., Pre-hematopoietic stem cell transplantation lung computed tomography is not an alternative to PFT for pediatric patients with sickle cell disease 2023
JCO Precision Oncology Goode E., Diagnostic and Prognostic Implications of GNAS Inactivation in Sonic Hedgehog-Activated Medulloblastoma: Case Report with Comprehensive Molecular Profiling and Review of Literature 6 2022
Pediatric Hematology and Oncology Goode E., Busulfan-based reduced toxicity conditioning regimen used in hematopoietic stem cell transplantation in HLH patients results in sustained donor chimerism 38:4 2021
Transfusion Nizzi F., Successful management of sirolimus toxicity in a hematopoietic stem cell transplant patient using automated red blood cell exchange 60:12 2020
Journal of Pediatric Hematology/Oncology Hickman K., Dasatinib-induced Chylothorax in Chronic Myelogenous Leukemia in Pediatric Patient: Report of a Case and Review of Literature 42:7 2020
Pediatric Hematology and Oncology Huschart E., Azacitidine and prophylactic donor lymphocyte infusions after hematopoietic stem cell transplantation for pediatric high-risk acute myeloid leukemia 38:2 2020
Transfusion Hess J., Successful treatment of severe refractory autoimmune hemolytic anemia after hematopoietic stem cell transplant with abatacept 58:9 2018
Biology of Blood and Marrow Transplantation Ngwube A., Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome 24:3 2018
Pediatric Blood and Cancer Beebe K., Vitamin D deficiency and outcomes in pediatric hematopoietic stem cell transplantation 65:2 2018
Journal of Pediatric Hematology/Oncology Madden L.M., Late toxicity of a novel allogeneic stem cell transplant using single fraction total body irradiation for hematologic malignancies in children 37:2 2015
Pediatric Blood and Cancer Ngwube A., Alemtuzumab based reduced intensity transplantation for pediatric severe aplastic anemia 62:7 2015
Journal of Clinical Rheumatology Kitcharoensakkul M., Scurvy revealed by difficulty walking: Three cases in young children 20:4 2014
Clinical Pediatrics Ngwube A., Disseminated Salmonella osetomyelitis in a 2-year-old with sickle cell disease 51:6 2012